The store will not work correctly when cookies are disabled.
4-(Cyclohexylmethoxy)-2-methoxybenzamide
ID: ALA5185276
PubChem CID: 163203933
Max Phase: Preclinical
Molecular Formula: C15H21NO3
Molecular Weight: 263.34
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1cc(OCC2CCCCC2)ccc1C(N)=O
Standard InChI: InChI=1S/C15H21NO3/c1-18-14-9-12(7-8-13(14)15(16)17)19-10-11-5-3-2-4-6-11/h7-9,11H,2-6,10H2,1H3,(H2,16,17)
Standard InChI Key: AELPJNFNRYUNNH-UHFFFAOYSA-N
Molfile:
RDKit 2D
19 20 0 0 0 0 0 0 0 0999 V2000
-1.7874 0.4121 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0728 0.8244 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3609 0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3609 -0.4126 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0710 -0.8244 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7874 -0.4163 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0710 -1.6496 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.3563 -2.0622 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3582 -1.6496 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0728 1.6496 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7875 2.0622 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.3582 2.0622 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.3536 0.8251 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.3536 1.6503 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3582 -0.8244 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0728 -0.4119 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7874 -0.8244 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7875 -1.6496 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0728 -2.0622 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
6 5 2 0
1 6 1 0
5 7 1 0
7 8 1 0
8 9 1 0
2 10 1 0
10 11 2 0
10 12 1 0
3 13 1 0
13 14 1 0
15 9 1 0
16 15 1 0
17 16 1 0
18 17 1 0
19 18 1 0
9 19 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 263.34 | Molecular Weight (Monoisotopic): 263.1521 | AlogP: 2.75 | #Rotatable Bonds: 5 |
Polar Surface Area: 61.55 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 13.78 | CX Basic pKa: ┄ | CX LogP: 2.62 | CX LogD: 2.62 |
Aromatic Rings: 1 | Heavy Atoms: 19 | QED Weighted: 0.89 | Np Likeness Score: -0.65 |
References
1. Nizi MG, Maksimainen MM, Murthy S, Massari S, Alaviuhkola J, Lippok BE, Sowa ST, Galera-Prat A, Prunskaite-Hyyryläinen R, Lüscher B, Korn P, Lehtiö L, Tabarrini O.. (2022) Potent 2,3-dihydrophthalazine-1,4-dione derivatives as dual inhibitors for mono-ADP-ribosyltransferases PARP10 and PARP15., 237 [PMID:35500474] [10.1016/j.ejmech.2022.114362] |